All News

Kirollos Hanna, PharmD, manager of Oncology Pharmacy at the University of Minnesota Medical Center, discusses the uptake of oncology biosimilars at his practice.

Ahead of Medicare open enrollment, which starts October 15, CMS released its annual report of which Medicare Advantage (MA) and Part D drug plans achieved 5-star ratings.

Comparing liver cancer survival across high-income countries has been difficult due to different standard and coding practices

Biomarkers for spinal muscular atrophy are needed to further analyze treatment efficacy, and a recent study points to serum neurofilament light chain levels as a possible option.

Pain is a hallmark of many Fabry disease cases, and improvements in management could dramatically improve quality of life for patients.

Mild cognitive impairment (MCI) affects older adults both with and without Parkinson disease (PD) and can impair the ability to participate in activities of daily living (IADL); a recent study sought to determine how both groups performed, compared with healthy adults, according to 4 measurements.

An overview of the significance of the Seema S. Sonnad Emerging Leader in Managed Care Research Award and why the early career achievements of this year's recipient, Christopher M. Whaley, PhD, in the field of managed care deserved recognition.

Leslie Eiland, MD, describes the importance of learning from the COVID-19 pandemic when it comes to ensuring continuous care for those with type 1 diabetes (T1D) during future pandemics.

An article looks at questions surrounding the long-term risks of polycystic ovary syndrome (PCOS).

Pediatric patients with extreme obstructive sleep apnea (OSA) may have a higher risk of needing respiratory support after undergoing corrective adenotonsillectomy, warranting the need for postoperative observation in these populations.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

New data show a decrease in COVID-19 deaths in the United States; long-term exposure to low levels of air pollution increases mortality risk; Moderna pressured to ramp up vaccine production.

Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, talks about the shift in focus that is needed to improve care for patients with asthma.

Bronchial hyperresponsiveness may indicate the presence of cough-variant asthma in nonsmokers who have chronic cough, new research shows.

Research presented during IDWeek 2021 showed data on V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine.

Duration of rheumatoid arthritis and use of corticosteroids were associated with higher risk of adverse outcomes following coronary artery bypass graft (CABG).

Focused educational improvements are needed for women of reproductive age and those who are pregnant regarding vertical transmission of HIV and its prevention.

A recent article describes the many challenges faced by patients with mast cell disorders, which involve unpredictable, disabling symptoms that interfere with daily life activities.

Sepsis is poorly understood, difficult to identify, and even harder to predict. Consistent stakeholder involvement may be key to identifying precisely where and how a sepsis early warning system could improve the team-based response to the condition.

A recently published review outlines progress made in discovering biomarkers for chronic myeloid leukemia (CML).

Pfizer and BioNTech ask FDA to authorize their COVID-19 vaccine in children; the World Health Organization (WHO) recommended widespread use of the world’s first malaria vaccine; a US judge blocks Texas’ strict abortion law.

A small pilot study revealed that music therapy may help reduce migraine frequency among patients with episodic migraine.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The case suggests lung transplantation can be a feasible option for patients with lung involvement.

New data on treatment for newly diagnosed pulmonary arterial hypertension (PAH) show initial treatment for the progressive disease that includes macitentan has potential to reduce risk of disease progression.

Some immunosuppressive medications, particularly anti-CD20 monoclonal antibodies, were found to reduce antibodies designed to protect against SARS-CoV-2 infection in patients with multiple sclerosis (MS) who have recovered from COVID-19, investigators concluded.

Patients with moderate to severe psoriasis were shown to achieve and maintain higher levels of complete skin clearance and quality of life when treated with brodalumab vs ustekinumab, regardless of the presence of lifestyle risk factors.

Anxiety and depression rates increased 13% and 14.8%, respectively, in 2020, before declining in 2021; Anthem Blue Cross and UnitedHealthcare are among major insurers behind on payments; a federal investigation discovered racial and gender-based pay discrimination among sales representatives at AstraZeneca.

Brazilian oncologists showed a solid knowledge base about biosimilars and their safety; however, concerns over extrapolation and interchangeability requirements remained, suggesting that more education on these subjects is needed.

Research presented at EHA2021 shows that the JAK 1/2 inhibitor ruxolitinib produced cost-effective benefits per quality-adjusted life-year and increased the overall survival rate for patients with myelofibrosis.